Ling Zhu
- Molecular Biology top 5%
- Biomedical Engineering top 5%
- Cancer Research top 5%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Topics
- Extracellular vesicles in disease (23 papers)MicroRNA in disease regulation (13 papers)Nanoplatforms for cancer theranostics (12 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ling Zhu
123 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Molecular Biology 1.6k
- Biomedical Engineering 666
- Cancer Research 605
- Oncology 456
- Pulmonary and Respiratory Medicine 278
Countries citing papers authored by Ling Zhu
This map shows the geographic impact of Ling Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Zhu more than expected).
Fields of papers citing papers by Ling Zhu
This network shows the impact of papers produced by Ling Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Zhu. The network helps show where Ling Zhu may publish in the future.
Co-authorship network of co-authors of Ling Zhu
This figure shows the co-authorship network connecting the top 25 collaborators of Ling Zhu. A scholar is included among the top collaborators of Ling Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Zhu. Ling Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 15 | |
| 4 | 13 | |
| 5 | 7 | |
| 6 | 12 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 9 | |
| 10 | 8 | |
| 11 | 2 | |
| 12 | 24 | |
| 13 | 8 | |
| 14 | 0 | |
| 15 | 4 | |
| 16 | 6 | |
| 17 | 30 | |
| 18 | 12 | |
| 19 | Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasisbreakdown → | 342 |
| 20 | 9 |
About Ling Zhu
Ling Zhu is a scholar working on Cancer Research, Molecular Biology and Immunology and Allergy, having authored 130 papers that have together received 2.8k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (23 papers), MicroRNA in disease regulation (13 papers) and Nanoplatforms for cancer theranostics (12 papers). The work is most often cited by research in Cancer Research (605 citations), Molecular Biology (1.6k citations) and Oncology (456 citations). Ling Zhu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Chen Wang, Huailei Ma, Yanlian Yang, Yanlian Yang, Wenzhe Li, Jin Zhang, Huayi Wang, Chen Wang, Zhiyuan Hu and Mengtao Sun. Their work appears in journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.